Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
pubmed:
24
3
2022
medline:
28
4
2022
entrez:
23
3
2022
Statut:
ppublish
Résumé
Kidney transplant patients are at high risk for coronavirus disease 2019 (COVID-19)-related mortality. However, limited data are available on longer-term clinical, functional, and mental health outcomes in patients who survive COVID-19. We analyzed data from adult kidney transplant patients in the European Renal Association COVID-19 Database who presented with COVID-19 between February 1, 2020, and January 31, 2021. We included 912 patients with a mean age of 56.7 (±13.7) y. 26.4% were not hospitalized, 57.5% were hospitalized without need for intensive care unit (ICU) admission, and 16.1% were hospitalized and admitted to the ICU. At 3 mo follow-up survival was 82.3% overall, and 98.8%, 84.2%, and 49.0%, respectively, in each group. At 3 mo follow-up biopsy-proven acute rejection, need for renal replacement therapy, and graft failure occurred in the overall group in 0.8%, 2.6%, and 1.8% respectively, and in 2.1%, 10.6%, and 10.6% of ICU-admitted patients, respectively. Of the surviving patients, 83.3% and 94.4% reached their pre-COVID-19 physician-reported functional and mental health status, respectively, within 3 mo. Of patients who had not yet reached their prior functional and mental health status, their treating physicians expected that 79.6% and 80.0%, respectively, still would do so within the coming year. ICU admission was independently associated with a low likelihood to reach prior functional and mental health status. In kidney transplant recipients alive at 3-mo follow-up, clinical, physician-reported functional, and mental health recovery was good for both nonhospitalized and hospitalized patients. Recovery was, however, less favorable for patients who had been admitted to the ICU.
Sections du résumé
BACKGROUND
Kidney transplant patients are at high risk for coronavirus disease 2019 (COVID-19)-related mortality. However, limited data are available on longer-term clinical, functional, and mental health outcomes in patients who survive COVID-19.
METHODS
We analyzed data from adult kidney transplant patients in the European Renal Association COVID-19 Database who presented with COVID-19 between February 1, 2020, and January 31, 2021.
RESULTS
We included 912 patients with a mean age of 56.7 (±13.7) y. 26.4% were not hospitalized, 57.5% were hospitalized without need for intensive care unit (ICU) admission, and 16.1% were hospitalized and admitted to the ICU. At 3 mo follow-up survival was 82.3% overall, and 98.8%, 84.2%, and 49.0%, respectively, in each group. At 3 mo follow-up biopsy-proven acute rejection, need for renal replacement therapy, and graft failure occurred in the overall group in 0.8%, 2.6%, and 1.8% respectively, and in 2.1%, 10.6%, and 10.6% of ICU-admitted patients, respectively. Of the surviving patients, 83.3% and 94.4% reached their pre-COVID-19 physician-reported functional and mental health status, respectively, within 3 mo. Of patients who had not yet reached their prior functional and mental health status, their treating physicians expected that 79.6% and 80.0%, respectively, still would do so within the coming year. ICU admission was independently associated with a low likelihood to reach prior functional and mental health status.
CONCLUSIONS
In kidney transplant recipients alive at 3-mo follow-up, clinical, physician-reported functional, and mental health recovery was good for both nonhospitalized and hospitalized patients. Recovery was, however, less favorable for patients who had been admitted to the ICU.
Identifiants
pubmed: 35320154
doi: 10.1097/TP.0000000000004075
pii: 00007890-202205000-00022
pmc: PMC9038249
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1012-1023Investigateurs
Jeroen B van der Net
(JB)
Marie Essig
(M)
Peggy W G du Buf-Vereijken
(PWG)
Betty van Ginneken
(B)
Nanda Maas
(N)
Liffert Vogt
(L)
Brigit C van Jaarsveld
(BC)
Frederike J Bemelman
(FJ)
Farah Klingenberg-Salahova
(F)
Frederiek Heenan-Vos
(F)
Marc G Vervloet
(MG)
Azam Nurmohamed
(A)
Daniel Abramowicz
(D)
Sabine Verhofstede
(S)
Omar Maoujoud
(O)
Thomas Malfait
(T)
Jana Fialova
(J)
Edoardo Melilli
(E)
Alexandre Favà
(A)
Josep M Cruzado
(JM)
Nuria Montero Perez
(N)
Joy Lips
(J)
Harmen Krepel
(H)
Harun Adilovic
(H)
Maaike Hengst
(M)
Constantijn Konings
(C)
Andrzej Rydzewski
(A)
Philippe Braconnier
(P)
Daniel Weis
(D)
Ryszard Gellert
(R)
João Oliveira
(J)
Daniela G Alferes
(DG)
Daniela Radulescu
(D)
Elena V Zakharova
(EV)
Patrice Max Ambuehl
(PM)
Rebecca Guidotti
(R)
Andrea Walker
(A)
Fanny Lepeytre
(F)
Clémentine Rabaté
(C)
Guy Rostoker
(G)
Sofia Marques
(S)
Tijana Azasevac
(T)
Gordana Strazmester Majstorovic
(G)
Dajana Katicic
(D)
Marc Ten Dam
(M)
Thilo Krüger
(T)
Szymon Brzosko
(S)
Vassilios Liakopoulos
(V)
Adriaan L Zanen
(AL)
Susan J J Logtenberg
(SJJ)
Lutz Fricke
(L)
Olexandr Kuryata
(O)
Jeroen J P Slebe
(JJP)
Samar Abd ElHafeez
(S)
Delphine Kemlin
(D)
Jacqueline van de Wetering
(J)
Marlies E J Reinders
(MEJ)
Dennis A Hesselink
(DA)
J Kal-van Gestel
(J)
Jaromir Eiselt
(J)
Lukas Kielberger
(L)
Hala S El-Wakil
(HS)
Martine Verhoeven
(M)
Ian Logan
(I)
Cristina Canal
(C)
Carme Facundo
(C)
Ana M Ramos
(AM)
Alicja Debska-Slizien
(A)
Nicoline M H Veldhuizen
(NMH)
Eirini Tigka
(E)
Maria Anna Polyzou Konsta
(MA)
Stylianos Panagoutsos
(S)
Francesca Mallamaci
(F)
Adele Postorino
(A)
Francesco Cambareri
(F)
Irina Matceac
(I)
Ionut Nistor
(I)
Adrian Covic
(A)
J H M Groeneveld
(JHM)
Jolanda Jousma
(J)
Marjolijn van Buren
(M)
Fritz Diekmann
(F)
Federico Oppenheimer
(F)
Miquel Blasco
(M)
Tiago Assis Pereira
(T)
Carlos Arias-Cabrales
(C)
Laura Llinàs-Mallol
(L)
Anna Buxeda
(A)
Carla Burballa Tàrrega
(CB)
Dolores Redondo-Pachon
(D)
Maria Dolores Arenas Jimenez
(MDA)
Alberto Mendoza-Valderrey
(A)
Ana Cristina Martins
(AC)
Catarina Mateus
(C)
Goncalo Alvila
(G)
Ivo Laranjinha
(I)
Julia M Hofstra
(JM)
Machiel A Siezenga
(MA)
Antonio Franco
(A)
David Arroyo
(D)
Sandra Castellano
(S)
Sagrario Balda Manzanos
(S)
R Haridian Sosa Barrios
(RH)
Wim Lemahieu
(W)
Karlijn Bartelet
(K)
Ahmet Burak Dirim
(A)
Mehmet Sukru Sever
(M)
Aydin Turkmen
(A)
Seda Şafak
(S)
Daan A M J Hollander
(DAMJ)
Stefan Büttner
(S)
Aiko P J de Vries
(APJ)
Soufian Meziyerh
(S)
Danny van der Helm
(D)
Marko Mallat
(M)
Hanneke Bouwsma
(H)
Sivakumar Sridharan
(S)
Kristina Petruliene
(K)
Sharon-Rose Maloney
(SR)
Iris Verberk
(I)
Frank M van der Sande
(FM)
Maarten H L Christiaans
(MHL)
N Mohan Kumar
(N)
Marina Di Luca
(M)
Serhan Z Tuğlular
(SZ)
Andrea Kramer
(A)
Charles Beerenhout
(C)
Peter T Luik
(PT)
Martin Tiefenthaler
(M)
Bruno Watschinger
(B)
Aaltje Y Adema
(AY)
Vadim A Stepanov
(VA)
Ilaria Gandolfini
(I)
Umberto Maggiore
(U)
Anselm Fliedner
(A)
Anders Åsberg
(A)
Geir Mjoen
(G)
Hitoshi Miyasato
(H)
Carola W H de Fijter
(CWH)
Nicola Mongera
(N)
Stefano Pini
(S)
Consuelo de Biase
(C)
Angele Kerckhoffs
(A)
Anne Els van de Logt
(AE)
Rutger Maas
(R)
Olga Lebedeva
(O)
Veronica Lopez
(V)
Louis J M Reichert
(LJM)
Jacobien Verhave
(J)
Denis Titov
(D)
Ekaterina V Parshina
(EV)
Luca Zanoli
(L)
Carmelita Marcantoni
(C)
Gijs van Kempen
(G)
Liesbeth E A van Gils-Verrij
(LEA)
John C Harty
(JC)
Marleen Meurs
(M)
Marek Myslak
(M)
Yuri Battaglia
(Y)
Paolo Lentini
(P)
Edwin den Deurwaarder
(E)
Maria Stendahl
(M)
Ivan Rychlik
(I)
Carlos J Cabezas-Reina
(CJ)
Ana Maria Roca
(A)
Ferdau Nauta
(F)
İdris Sahin
(İ)
Eric Goffin
(E)
Nada Kanaan
(N)
Laura Labriola
(L)
Arnaud Devresse
(A)
Anabel Diaz-Mareque
(A)
Armando Coca
(A)
Gabriel de Arriba
(G)
Björn K I Meijers
(BKI)
Maarten Naesens
(M)
Bruno Desschans
(B)
Annelies Tonnerlier
(A)
Karl M Wissing
(KM)
Ivana Dedinska
(I)
Giuseppina Pessolano
(G)
Shafi Malik
(S)
Evangelia Dounousi
(E)
Evangelos Papachristou
(E)
Stefan P Berger
(SP)
Esther Meijer
(E)
Jan Stephan F Sanders
(JSF)
Akin Özyilmaz
(A)
Jadranka Buturović Ponikvar
(J)
Andreja Marn Pernat
(A)
Damjan Kovac
(D)
Miha Arnol
(M)
Robert Ekart
(R)
Alferso C Abrahams
(AC)
Femke M Molenaar
(FM)
Arjan D van Zuilen
(AD)
Sabine C A Meijvis
(SCA)
Helma Dolmans
(H)
Ekamol Tantisattamo
(E)
Pasquale Esposito
(P)
Jean-Marie Krzesinski
(JM)
Jean Damacène Barahira
(JD)
Maurizio Gallieni
(M)
Paloma Leticia Martin-Moreno
(PL)
Gabriele Guglielmetti
(G)
Gabriella Guzzo
(G)
Nestor Toapanta
(N)
Maria Jose Soler
(M)
Antinus J Luik
(AJ)
Willi H M van Kuijk
(WHM)
Lonneke W H Stikkelbroeck
(LWH)
Marc M H Hermans
(MMH)
Laurynas Rimsevicius
(L)
Marco Righetti
(M)
Mahmud Islam
(M)
Nicole Heitink-Ter Braak
(N)
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
World Health Organization. WHO coronavirus (COVID-19) dashboard. Available at https://covid19.who.int . Accessed January 6, 2022.
Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436.
Morin L, Savale L, Pham T, et al.; Writing Committee for the COMEBAC Study Group. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325:1525–1534.
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–232.
Hilbrands LB, Duivenvoorden R, Vart P, et al.; ERACODA Collaborators. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020;35:1973–1983.
Caillard S, Chavarot N, Francois H, et al.; French SOT COVID Registry. Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021;21:1295–1303.
Crespo M, Mazuecos A, Rodrigo E, et al.; Spanish Society of Nephrology COVID-19 Group. Respiratory and gastrointestinal COVID-19 phenotypes in kidney transplant recipients. Transplantation. 2020;104:2225–2233.
Villanego F, Mazuecos A, Pérez-Flores IM, et al.; Spanish Society of Nephrology COVID-19 Group. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: analysis of the Spanish Registry. Am J Transplant. 2021;21:2573–2582.
Kates OS, Haydel BM, Florman SS, et al.; UW COVID-19 SOT Study Team. Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study. Clin Infect Dis. 2021;73:e4090–e4099.
Jager KJ, Kramer A, Chesnaye NC, et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98:1540–1548.
Noordzij M, Duivenvoorden R, Pena MJ, et al.; collaborative ERACODA authors. ERACODA: the European database collecting clinical information of patients on kidney replacement therapy with COVID-19. Nephrol Dial Transplant. 2020;35:2023–2025.
Harris PA, Taylor R, Minor BL, et al.; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–495.
Liu Y, De A. Multiple imputation by fully conditional specification for dealing with missing data in a large epidemiologic study. Int J Stat Med Res. 2015;4:287–295.
Volbeda M, Hessels L, Posma RA, et al. Time courses of urinary creatinine excretion, measured creatinine clearance and estimated glomerular filtration rate over 30 days of ICU admission. J Crit Care. 2021;63:161–166.
Toapanta N, Torres IB, Sellarés J, et al. Kidney transplantation and COVID-19 renal and patient prognosis. Clin Kidney J. 2021;14:i21–i29.
Marinelli T, Ferreira VH, Ierullo M, et al. Prospective clinical, virologic, and immunologic assessment of COVID-19 in transplant recipients. Transplantation. 2021;105:2175–2183.
De Meester J, De Bacquer D, Naesens M, et al.; NBVN Kidney Registry Group. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study. J Am Soc Nephrol. 2021;32:385–396.
Ali T, Al-Ali A, Fajji L, et al. Coronavirus disease-19: disease severity and outcomes of solid organ transplant recipients: different spectrums of disease in different populations? Transplantation. 2021;105:121–127.
Kudose S, Batal I, Santoriello D, et al. Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol. 2020;31:1959–1968.
Anton Pampols PA, Trujillo H, Melilli E, et al. Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19. Clin Kidney J. 2021;14:1229–1235.
Mahalingasivam V, Craik A, Tomlinson LA, et al. A systematic review of COVID-19 and kidney transplantation. Kidney Int Rep. 2021;6:24–45.
Elias M, Pievani D, Randoux C, et al. COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31:2413–2423.
Cohen SB, Strand V, Aguilar D, et al. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology (Oxford). 2004;43:704–711.